65 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

239

Pak Fah Yeow International
HK$2.120%46.2%HK$660.7mn/aPE6.3xn/a9.7%

1652

Fusen Pharmaceutical
HK$0.88-2.2%-34.8%HK$650.6mn/aPS1.1xn/a0%

6998

Genor Biopharma Holdings
HK$1.25-2.3%-32.8%HK$635.9mn/aPB0.5xn/an/a

2257

Sirnaomics
HK$7.1213.0%-86.1%HK$618.1mHK$72.19PS1978.3xS58.2%n/a

455

Tianda Pharmaceuticals
HK$0.271.9%32.4%HK$580.5mn/aPS1.1xn/a1.0%

9939

Kintor Pharmaceutical
HK$1.2126.0%-77.0%HK$541.5mHK$14.51PB1.1xE27.0%n/a

690

Uni-Bio Science Group
HK$0.084-1.2%55.6%HK$517.7mn/aPE7.3xn/an/a

6118

Austar Lifesciences
HK$0.73-11.0%-61.4%HK$374.2mn/aPB0.4xn/a0%

1498

PuraPharm
HK$0.772.7%-28.0%HK$304.2mn/aPB2xn/a0%

897

Wai Yuen Tong Medicine Holdings
HK$0.230%-42.5%HK$258.8mn/aPE7.1xn/a0%

8329

Shenzhen Neptunus Interlong Bio-technique
HK$0.15-5.8%3.5%HK$246.7mn/aPE9.5xn/an/a

1643

Modern Chinese Medicine Group
HK$0.326.7%-32.6%HK$192.0mn/aPE3.6xn/a0%

1312

Kontafarma China Holdings
HK$0.0320%-20.0%HK$178.8mn/aPB0.2xn/a0%

8247

Biosino Bio-Technology and Science Incorporation
HK$0.90-4.3%-14.3%HK$130.2mn/aPB0.6xn/a0%

1889

Sanai Health Industry Group
HK$0.0287.7%-65.9%HK$107.0mn/aPE5.3xn/a0%

858

Extrawell Pharmaceutical Holdings
HK$0.0283.7%-55.6%HK$66.9mn/aPB0.06xn/an/a

8158

China Regenerative Medicine International
HK$0.18-32.6%-83.3%HK$55.4mn/aPB4.7xn/an/a
Page 3 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.